These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10522458)

  • 21. [St. John's wort extract WS 5572 in minor to moderately severe depression. Effectiveness and tolerance of 600 and 1200 mg active ingredient daily].
    Rychlik R; Siedentop H; von den Driesch V; Kasper S
    Fortschr Med Orig; 2001 Nov; 119(3-4):119-28. PubMed ID: 11789123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of hypericum extract on cardiac conduction as seen in the electrocardiogram compared to that of imipramine.
    Czekalla J; Gastpar M; Hübner WD; Jäger D
    Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():86-8. PubMed ID: 9342766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. St. John's Wort extract: efficacy for menopausal symptoms of psychological origin.
    Grube B; Walper A; Wheatley D
    Adv Ther; 1999; 16(4):177-86. PubMed ID: 10623319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. St John's wort or sertraline? Randomized controlled trial in primary care.
    van Gurp G; Meterissian GB; Haiek LN; McCusker J; Bellavance F
    Can Fam Physician; 2002 May; 48():905-12. PubMed ID: 12053635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypericum perforatum: nature's mood stabilizer.
    Kumar V; Singh PN; Muruganandam AV; Bhattacharya SK
    Indian J Exp Biol; 2000 Nov; 38(11):1077-85. PubMed ID: 11395949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Incidence and clinical relevance of interactions and side-effects of hypericum preparations].
    Schulz V
    Praxis (Bern 1994); 2000 Dec; 89(50):2131-40. PubMed ID: 11155496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study.
    Anghelescu IG; Kohnen R; Szegedi A; Klement S; Kieser M
    Pharmacopsychiatry; 2006 Nov; 39(6):213-9. PubMed ID: 17124643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: a reanalysis of data from a controlled clinical trial.
    Singer A; Schmidt M; Hauke W; Stade K
    Phytomedicine; 2011 Jun; 18(8-9):739-42. PubMed ID: 21514125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [For mild to moderate depression. Thesis paper recommends Hypericum].
    MMW Fortschr Med; 2001 Aug; 143(31-32):43-4. PubMed ID: 11556190
    [No Abstract]   [Full Text] [Related]  

  • 30. Effectiveness and tolerance of the hypericum extract LI 160 compared to maprotiline: a multicenter double-blind study.
    Harrer G; Hübner WD; Podzuweit H
    J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S24-8. PubMed ID: 7857503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of depressive symptoms with a high concentration hypericum preparation. A multicenter placebo-controlled double-blind study].
    Witte B; Harrer G; Kaptan T; Podzuweit H; Schmidt U
    Fortschr Med; 1995 Oct; 113(28):404-8. PubMed ID: 7498868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of hypericum extract STW3 in long-term treatment with a once-daily dosage in comparison with sertraline.
    Gastpar M; Singer A; Zeller K
    Pharmacopsychiatry; 2005 Mar; 38(2):78-86. PubMed ID: 15744631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients--a controlled 6-week clinical trial.
    Wheatley D
    Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():77-80. PubMed ID: 9342764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and tolerance of the hypericum extract LI 160 in comparison with imipramine: randomized double-blind study with 135 outpatients.
    Vorbach EU; Hübner WD; Arnoldt KH
    J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S19-23. PubMed ID: 7857502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling the recovery from depressive illness by an exponential model with mixed effects.
    Friede T; Kieser M; Miller F
    Methods Inf Med; 2000 Mar; 39(1):12-5. PubMed ID: 10786064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy of St. John's Wort in patients with minor depressive symptoms or dysthymia--a double-blind placebo-controlled study.
    Randløv C; Mehlsen J; Thomsen CF; Hedman C; von Fircks H; Winther K
    Phytomedicine; 2006 Mar; 13(4):215-21. PubMed ID: 16423519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benefits and risks of the hypericum extract LI 160: drug monitoring study with 3250 patients.
    Woelk H; Burkard G; Grünwald J
    J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S34-8. PubMed ID: 7857506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse neuropsychiatric reactions to herbal and over-the-counter "antidepressants".
    Pies R
    J Clin Psychiatry; 2000 Nov; 61(11):815-20. PubMed ID: 11105733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial.
    Volz HP; Murck H; Kasper S; Möller HJ
    Psychopharmacology (Berl); 2002 Nov; 164(3):294-300. PubMed ID: 12424553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Laif 900: setting the course for compliance. Diagnosis of depression: a special challenge for physician and patient (interview by Marianne E. Tippmann)].
    Niederberger M
    MMW Fortschr Med; 2011 Jul; 153(29-31):53. PubMed ID: 21830742
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.